🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareHair loss on GLP-1 agonists: telogen effluvium vs nutritional deficiency — 6 month update Page 5

Hair loss on GLP-1 agonists: telogen effluvium vs nutritional deficiency — 6 month update

TrialTracker_MD Tue, Nov 11, 2025 at 4:36 PM 23 replies 1,449 viewsPage 5 of 5
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Nov 28, 2025 at 3:36 AM#21
gary_naperville said:
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

Can confirm. Same sequence, different timescale. The detail I would add is minor and it is already implied above.

29 4PurityPaulOR, MaxMetOK, MounjBrad and 26 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Dec 4, 2025 at 5:21 AM#22
gary_naperville said:
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

There is a second half to this that has not been said yet. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

28 3roxy_nash, tony_orlando, Dr.NephBHM_UK and 25 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Dec 10, 2025 at 7:09 AM#23

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

27 2KevinCompounds, TirzTom, TrialTracker_MD and 24 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Dec 16, 2025 at 9:01 AM#24

One thing that is still open after gary_naperville’s answer:

What did you change at the same time, and can you separate the two now?

26 1PeptideChemSF, A1cHero_PHX, Dr.RenalNash and 23 others
Reply Quote Save Share Report
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Dec 22, 2025 at 10:56 AM#25
stefan_berlin said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

25 0mel_PDX, Dr.AddMedPHL, newstart_MO and 22 others
Reply Quote Save Share Report
1345

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register